Lördag 25 April | 18:23:29 Europe / Stockholm
Svenska | English

BioStock

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Correction: Pila Pharma’s unanticipated obesity results plausibly explained by low drug exposure, analyses confirms
2026-04-17 09:58:00

Correction in headline and preamble.

Swedish biotech Pila Pharma has announced a highly anticipated update to its preclinical obesity studies, concluding that the absence of an effect on body weight and other inflammatory markers in rats was most likely caused by insufficient drug exposure rather than lack of efficacy. The company is now pressing ahead with clinical preparations. BioStock reached out to CEO Gustav H. Gram to learn more.

Read the full article at biostock.se:
https://biostock.se/en/2026/04/pila-pharmas-prekliniska-resultat-forklaras-sannolikt-av-lag-lakemedelsexponering/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter 
Follow BioStock on social media: LinkedIn and Facebook!  
 
About BioStock 
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.  
BioStock – Connecting Innovation & Capital. 

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden